161 related articles for article (PubMed ID: 7540219)
21. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Hirabayashi K; Okada E
Jpn J Antibiot; 1984 Nov; 37(11):2223-33. PubMed ID: 6098716
[TBL] [Abstract][Full Text] [Related]
22. [Clinical evaluation of sulbactam/cefoperazone in the pediatric infections].
Meguro H; Tajima T; Nonaka C; Mashiko J; Fujii R; Arimasu O
Jpn J Antibiot; 1984 Oct; 37(10):1821-30. PubMed ID: 6094862
[TBL] [Abstract][Full Text] [Related]
23. [An evaluation of a therapy with antibacterial and antifungal agents infections with hematological disorders].
Inoue N; Takemoto Y; Kanamaru A; Kakishita E; Nakayama S; Hara H; Tsutsui T; Murakami R; Yamaguchi N; Tago H
Jpn J Antibiot; 1993 Jun; 46(6):486-91. PubMed ID: 8360984
[TBL] [Abstract][Full Text] [Related]
24. [Studies on the combined effect of fosfomycin with sulbactam/cefoperazone on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa].
Niida M; Yoshida T; Kohmoto A; Ogawa M; Hashimoto H; Deguchi K
Jpn J Antibiot; 1994 Jan; 47(1):1-10. PubMed ID: 8114267
[TBL] [Abstract][Full Text] [Related]
25. [Clinical evaluation of sulbactam/cefoperazone for infections in the field of obstetrics and gynecology].
Chimura T; Inoue K; Morisaki N
Jpn J Antibiot; 1984 Oct; 37(10):1928-33. PubMed ID: 6094871
[TBL] [Abstract][Full Text] [Related]
26. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
Suzuki K; Horiba M
Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
[TBL] [Abstract][Full Text] [Related]
27. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Yamamoto T; Yasuda J; Kanao M; Okada H
Jpn J Antibiot; 1984 Nov; 37(11):2213-22. PubMed ID: 6098715
[TBL] [Abstract][Full Text] [Related]
28. [Experimental and clinical studies of sulbactam/cefoperazone in pediatric field].
Nakashima T; Ueda S; Hayakawa F; Miyachi Y; Hakamada S; Kuno K
Jpn J Antibiot; 1984 Oct; 37(10):1846-58. PubMed ID: 6094864
[TBL] [Abstract][Full Text] [Related]
29. [Studies on sulbactam/cefoperazone in the field of pediatrics].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
[TBL] [Abstract][Full Text] [Related]
30. [Fundamental and clinical studies of sulbactam/cefoperazone in the field of pediatrics].
Nakazawa S; Sato H; Narita A; Nakazawa S; Suzuki H; Chikaoka H; Tazoe K
Jpn J Antibiot; 1984 Nov; 37(11):2174-87. PubMed ID: 6098710
[TBL] [Abstract][Full Text] [Related]
31. [Experience with sulbactam/cefoperazone in the field of obstetrics and gynecology].
Kohara T; Matsui Y; Noda M; Hirai S; Iida S
Jpn J Antibiot; 1984 Oct; 37(10):1934-8. PubMed ID: 6094872
[TBL] [Abstract][Full Text] [Related]
32. [Clinical studies of sulbactam/cefoperazone therapy in pediatric bacterial infections].
Nakamura A; Himi K; Matsumura C; Suzuki H; Kurosaki T; Sugaya N; Terashima I; Uehara S
Jpn J Antibiot; 1984 Oct; 37(10):1793-800. PubMed ID: 6094859
[TBL] [Abstract][Full Text] [Related]
33. [Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Doko F
Jpn J Antibiot; 1984 Nov; 37(11):2243-50. PubMed ID: 6098718
[TBL] [Abstract][Full Text] [Related]
34. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
Iwata S; Sato Y; Iwasaki Y; Hayano S; Wakabayashi R; Kojima Y; Akita H; Sunakawa K; Oikawa T; Osano M
Jpn J Antibiot; 1984 Oct; 37(10):1831-45. PubMed ID: 6094863
[TBL] [Abstract][Full Text] [Related]
35. [Clinical and bacteriological efficiency of sulbactam/cefoperazone in gynecological infectious diseases].
Saito Y; Tachizaki T; Maki M
Jpn J Antibiot; 1984 Oct; 37(10):1919-24. PubMed ID: 6094869
[TBL] [Abstract][Full Text] [Related]
36. [Fundamental and clinical studies of sulbactam/cefoperazone in obstetrics and gynecology].
Kubota K
Jpn J Antibiot; 1984 Nov; 37(11):2234-42. PubMed ID: 6098717
[TBL] [Abstract][Full Text] [Related]
37. [Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field].
Fujii R; Meguro H; Arimasu O; Mashiko J; Tajima T; Nonaka C; Nagamatsu I; Sato Y; Honjo T; Watanabe A
Jpn J Antibiot; 1984 Dec; 37(12):2427-56. PubMed ID: 6098739
[TBL] [Abstract][Full Text] [Related]
38. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of piperacillin, latamoxef, ceftazidime, fosfomycin and doxycycline].
Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
Jpn J Antibiot; 1990 Apr; 43(4):636-58. PubMed ID: 2199689
[TBL] [Abstract][Full Text] [Related]
39. [Passage into the human milk and clinical evaluation of sulbactam/cefoperazone].
Matsuda S; Kashiwagura T; Hirayama H
Jpn J Antibiot; 1985 Feb; 38(2):223-9. PubMed ID: 2989572
[TBL] [Abstract][Full Text] [Related]
40. [Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Ikegawa A; Seto H; Hogaki M; Arai K
Jpn J Antibiot; 1984 Nov; 37(11):2188-92. PubMed ID: 6098711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
